Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam | Zendy

Antti Mustonen | Zendy; J. Leijala | Zendy; Johanna Aronranta | Zendy; Antero Lassila | Zendy; Mauri Aalto | Zendy; Janne Koskimäki | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam

Author(s) -

Antti Mustonen,

J. Leijala,

Johanna Aronranta,

Antero Lassila,

Mauri Aalto,

Janne Koskimäki

Publication year - 2021

Publication title -

case reports in psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.17

H-Index - 4

eISSN - 2090-682X

pISSN - 2090-6838

DOI - 10.1155/2021/2140723

Subject(s) - oxazepam , medicine , benzodiazepine , tapering , anxiety , psychiatry , protocol (science) , anesthesia , emergency medicine , pediatrics , alternative medicine , computer graphics (images) , receptor , computer science , pathology

Benzodiazepine (BZD) misuse is a worldwide problem that healthcare professionals encounter in daily practice. High-dose BZD withdrawal is usually a long process that may require referral to an inpatient rehabilitation unit. Relapses after withdrawal are common. BZD withdrawal can cause complications including seizures, suicidal behavior, anxiety, and depression. Guidelines describe tapering protocols for modest doses; however, protocols for exceptionally high-dose BZD withdrawal are not well described. Herein, we describe a BZD tapering protocol for a patient with daily use of high-dose (1800 mg) oxazepam (OXP). The BZD tapering was administered in an inpatient psychiatric hospital, and the outcome was evaluated monthly after discharge for three months. This report describes a unique case of high-dose OXP withdrawal and also outlines an optional protocol to apply when clinicians encounter these unusual cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research